Clinical Trials Insight: 700044738
Latest Information Update: 22 May 2009
At a glance
- Drugs PSN 602 (Primary) ; Sibutramine
- Indications Obesity
- Focus Therapeutic Use
- Sponsors OSI Pharmaceuticals
Most Recent Events
- 20 May 2009 New trial record.
Latest Information Update: 22 May 2009